JPRN-UMIN000002854已完成未知
Evaluation of efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration - Efficacy of topical bromfenac for exudative age-related macular degeneration
Department of Ophthalmology, Osaka University Medical School0 个研究点目标入组 30 人开始时间: 2009年12月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •choroidal neovascularization secondary to pathorogical myopia or other diseases
研究者
相似试验
已完成
不适用
Evaluation of efficacy of topical bromfenac (0.1%) as an adjunctive therapy for patients with retinal vein occlusioretinal vein occlusionJPRN-UMIN000013410Department of Ophthalmology, Shiga University of Medical Science40
进行中（未招募）
1 期
Effect of topical bromfenac in the perception of pain after intravitreal injection of drugsEUCTR2015-002155-10-ESFISEVI Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla
已完成
3 期
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract SurgeryPainInflammationNCT00333918Bausch & Lomb Incorporated522
撤回
2 期
Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.Cystoid Macular EdemaNCT00438243Johns Hopkins University
已完成
3 期
Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract SurgeryPostoperative ComplicationsCataractNCT00198445Bausch & Lomb Incorporated527